Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria

[1]  Irine Ronin,et al.  Effect of tolerance on the evolution of antibiotic resistance under drug combinations , 2020, Science.

[2]  Allison M Murawski,et al.  Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic , 2019, Nature Communications.

[3]  D. J. Kiviet,et al.  Effective polyploidy causes phenotypic delay and influences bacterial evolvability , 2017, bioRxiv.

[4]  W. Jacobs,et al.  Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations , 2017, Proceedings of the National Academy of Sciences.

[5]  R. Warren,et al.  Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis. , 2016, American journal of respiratory and critical care medicine.

[6]  D. Schnappinger,et al.  Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis , 2016, ACS infectious diseases.

[7]  Kim A. Hatch,et al.  A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action , 2016, Antimicrobial Agents and Chemotherapy.

[8]  Vincent O. Baron,et al.  Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you? , 2015, The Journal of antimicrobial chemotherapy.

[9]  R. Austin,et al.  Emergence of antibiotic resistance from multinucleated bacterial filaments , 2014, Proceedings of the National Academy of Sciences.

[10]  Malika Charrad,et al.  NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set , 2014 .

[11]  H. Shapiro,et al.  Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach. , 2014, Tuberculosis.

[12]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[13]  D. Mitchison,et al.  Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. , 2014, The Journal of antimicrobial chemotherapy.

[14]  P. V. van Helden,et al.  Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. , 2014, The Journal of antimicrobial chemotherapy.

[15]  JoAnne L. Flynn,et al.  Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2014 .

[16]  C. de Chastellier,et al.  Reversible Lipid Accumulation and Associated Division Arrest of Mycobacterium avium in Lipoprotein-Induced Foamy Macrophages May Resemble Key Events during Latency and Reactivation of Tuberculosis , 2013, Infection and Immunity.

[17]  R. Cox,et al.  Evaluation of the cell growth of mycobacteria using Mycobacterium smegmatis mc2 155 as a representative species , 2012, Journal of Microbiology.

[18]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[19]  D. Mitchison,et al.  The chemotherapy of tuberculosis: past, present and future [State of the art]. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  R. Wilkinson,et al.  Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. , 2012, Drug discovery today.

[21]  B. Kana,et al.  Dried Culture Spots for Xpert MTB/RIF External Quality Assessment: Results of a Phase 1 Pilot Study in South Africa , 2011, Journal of Clinical Microbiology.

[22]  M. Venter,et al.  Antibiotic Susceptibility of Multi-drug resistant Mycobacterium tuberculosis using Flow Cytometry , 2010 .

[23]  Alan T. Bull,et al.  The renaissance of continuous culture in the post-genomics age , 2010, Journal of Industrial Microbiology & Biotechnology.

[24]  Willy Verstraete,et al.  Past, present and future applications of flow cytometry in aquatic microbiology. , 2010, Trends in biotechnology.

[25]  S. Müller,et al.  Functional single-cell analyses: flow cytometry and cell sorting of microbial populations and communities. , 2010, FEMS microbiology reviews.

[26]  G. Davies.  Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity. , 2010, Tuberculosis.

[27]  M. Barer,et al.  Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum. , 2010, American journal of respiratory and critical care medicine.

[28]  David R. Hunter,et al.  mixtools: An R Package for Analyzing Mixture Models , 2009 .

[29]  D. Hunter,et al.  mixtools: An R Package for Analyzing Mixture Models , 2009 .

[30]  S. Lovett,et al.  Cell cycle synchronization of Escherichia coli using the stringent response, with fluorescence labeling assays for DNA content and replication. , 2009, Methods.

[31]  S. Yoshida,et al.  Discrimination of live, anti-tuberculosis agent-injured, and dead Mycobacterium tuberculosis using flow cytometry. , 2009, FEMS microbiology letters.

[32]  Robert Gentleman,et al.  flowCore: a Bioconductor package for high throughput flow cytometry , 2009, BMC Bioinformatics.

[33]  W. Jacobs,et al.  Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis , 2009, PloS one.

[34]  Kemin Wang,et al.  Using fluorescent nanoparticles and SYBR Green I based two-color flow cytometry to determine Mycobacterium tuberculosis avoiding false positives. , 2008, Biosensors & bioelectronics.

[35]  S. Günther,et al.  Limits of propidium iodide as a cell viability indicator for environmental bacteria , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  R. Schell,et al.  Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. , 2006, Journal of microbiological methods.

[37]  V. Mizrahi,et al.  Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy , 2006, Clinical Microbiology Reviews.

[38]  L. Salazar,et al.  Permeabilization of the mycobacterial envelope for protein cytolocalization studies by immunofluorescence microscopy , 2006, BMC Microbiology.

[39]  Paul A Hoskisson,et al.  Continuous culture--making a comeback? , 2005, Microbiology.

[40]  Y. Akselband,et al.  Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. , 2005, Journal of microbiological methods.

[41]  R. Schell,et al.  Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[42]  R. Seviour,et al.  Improved permeabilization protocols for fluorescence in situ hybridization (FISH) of mycolic-acid-containing bacteria found in foams. , 2005, Journal of microbiological methods.

[43]  M. Lourenço,et al.  Comparison of Flow Cytometric and Alamar Blue Tests with the Proportional Method for Testing Susceptibility of Mycobacterium tuberculosis to Rifampin and Isoniazid , 2004, Journal of Clinical Microbiology.

[44]  A. Rodrigues,et al.  Novel Method Using a Laser Scanning Cytometer for Detection of Mycobacteria in Clinical Samples , 2004, Journal of Clinical Microbiology.

[45]  T. Burdz,et al.  Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry. , 2003, Diagnostic microbiology and infectious disease.

[46]  D. Mitchison,et al.  Sources of variation in studies of the early bactericidal activity of antituberculosis drugs. , 2001, The Journal of antimicrobial chemotherapy.

[47]  R. Schell,et al.  Flow cytometric testing of susceptibilities of Mycobacterium avium to amikacin, ciprofloxacin, clarithromycin and rifabutin in 24 hours. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[48]  P. Marsh,et al.  The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium , 2000, Journal of applied microbiology.

[49]  L. Jones,et al.  Characterization of SYBR Gold nucleic acid gel stain: a dye optimized for use with 300-nm ultraviolet transilluminators. , 1999, Analytical biochemistry.

[50]  S. Kirk,et al.  Safe Determination of Susceptibility of Mycobacterium tuberculosis to Antimycobacterial Agents by Flow Cytometry , 1999, Journal of Clinical Microbiology.

[51]  P. Hsueh,et al.  Use of fluorescein labelled antibody and fluorescence activated cell sorter for rapid identification of Mycobacterium species. , 1998, Biochemical and biophysical research communications.

[52]  S. Kirk,et al.  Flow Cytometric Testing of Susceptibilities ofMycobacterium tuberculosis Isolates to Ethambutol, Isoniazid, and Rifampin in 24 Hours , 1998, Journal of Clinical Microbiology.

[53]  M. Barer,et al.  SYTO16 labelling and flow cytometry of Mycobacterium avium , 1997, Letters in applied microbiology.

[54]  D. Deere,et al.  Go with the flow – use of flow cytometry in environmental microbiology , 1997 .

[55]  M. Egorin,et al.  Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group. , 1997, American journal of respiratory and critical care medicine.

[56]  D. Kell,et al.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses. , 1996, Microbiological reviews.

[57]  D. Kell,et al.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses , 1996 .

[58]  R. Schell,et al.  Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry , 1996, Journal of Clinical Microbiology.

[59]  T. Åkerlund,et al.  Analysis of cell size and DNA content in exponentially growing and stationary-phase batch cultures of Escherichia coli , 1995, Journal of bacteriology.

[60]  S. Sullivan,et al.  Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation , 1995, Journal of clinical microbiology.

[61]  R. Schell,et al.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry , 1995, Journal of clinical microbiology.

[62]  C. Parish,et al.  New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. , 1990, Journal of immunological methods.

[63]  S. Schuldiner,et al.  Bacterial membrane potential analyzed by spectrofluorocytometry , 1985, Current Microbiology.

[64]  L. Wayne,et al.  Synchronized replication of Mycobacterium tuberculosis , 1977, Infection and immunity.

[65]  M. Lamers,et al.  DNA Replication in Mycobacterium tuberculosis , 2017, Microbiology spectrum.

[66]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[67]  J. Mckinney,et al.  A single-cell perspective on non-growing but metabolically active (NGMA) bacteria. , 2013, Current topics in microbiology and immunology.

[68]  S. Sutton.  Accuracy of Plate Counts , 2011 .

[69]  H. Shapiro.  Flow cytometry of bacterial membrane potential and permeability. , 2008, Methods in molecular medicine.

[70]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[71]  C. Sohaskey,et al.  Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.

[72]  C Laplace-Builhé,et al.  Application of flow cytometry to rapid microbial analysis in food and drinks industries , 1993, Biology of the cell.